| Financial Year |
March 31 2023 |
| Monetary Funds |
995,464,929.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,263,010,877.47 |
| Advances to Suppliers |
184,488,005.70 |
| Other Receivables |
204,927,288.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,489,954,870.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
196,405,099.95 |
| Total Current Assets |
7,501,296,082.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,063,686,243.77 |
| Investment Properties |
1,043,352,401.00 |
| Fixed Assetes |
836,870,830.52 |
| Under-construction Projects |
52,425,730.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
242,026,206.69 |
| R&D expenses |
8,196,024.35 |
| Goodwill |
1,094,232,030.52 |
| Long-Term Deferred and Prepaid Expenses |
72,053,768.29 |
| Deferred Income Tax Assets |
160,794,107.59 |
| Other Non-Current Assets |
32,344,004.18 |
| Sub-Total of Non-Current Assets |
6,359,274,034.63 |
| Total Assets |
13,860,570,116.84 |
| Short-Term Loans |
2,583,983,936.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
220,653,860.20 |
| Accounts Payable |
2,216,554,440.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
174,942,438.89 |
| Taxes Payable |
54,654,555.10 |
| Interest Payable |
2,883,226.82 |
| Dividend Payable |
101,988.26 |
| Other payables |
589,977,612.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
199,798,925.32 |
| Other Current Liabilities |
725,335,738.52 |
| Sub-Total of Current Liabilities |
7,755,487,015.99 |
| Long-term Loans |
222,561,500.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
62,839,940.96 |
| Deferred Income Tax Liabilities |
86,848,614.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
484,778,177.42 |
| Total Liabilities |
8,240,265,193.41 |
| Paid-In Capital(Or Share Stock) |
1,314,925,152.00 |
| Capital Surplus |
1,775,308,272.56 |
| Surplus Reserve |
122,513,859.01 |
| LESS:Treasury Stock |
22,783,500.00 |
| Undistributed Profits |
1,761,538,726.95 |
| Minority Stockholder's Interest |
555,283,536.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,065,021,387.16 |
| Owner's Equity（Stockholder's Equity） |
5,620,304,923.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,860,570,116.84 |
